Literature DB >> 23205096

Increased numbers of gastric-infiltrating mast cells and regulatory T cells are associated with tumor stage in gastric adenocarcinoma patients.

Yibin Zhao1, Ke Wu, Kailin Cai, Ronglin Zhai, Kaixiong Tao, Guobin Wang, Jiliang Wang.   

Abstract

Mast cells (MCs) and regulatory T cells (Tregs) are the important components of the inflammatory infiltrating leukocytes in most malignant tumors. Our study was designed to investigate the infiltrating correlation between MCs and Tregs and clarify their prognostic significance in gastric cancer (GC). A total of 60 fresh GC tissues were collected and tumor-infiltrating leukocytes were isolated by gradient centrifugation. Tryptase and Foxp3 were used as markers for MCs and Tregs, respectively. The expression of tryptase and Foxp3 was determined in tumor-infiltrating leukocytes using flow cytometry. The expression of tryptase and Foxp3 were positively correlated. The increased infiltration of MCs correlated significantly with advanced stage of GC. The infiltration of MCs into the tumor may increase the number of Tregs. Tryptase is a promising marker to stratify GC patients into different risk groups.

Entities:  

Year:  2012        PMID: 23205096      PMCID: PMC3506702          DOI: 10.3892/ol.2012.830

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.

Authors:  Koji Kono; Hiromichi Kawaida; Akihiro Takahashi; Hidemitsu Sugai; Kosaku Mimura; Naoto Miyagawa; Hideo Omata; Hideki Fujii
Journal:  Cancer Immunol Immunother       Date:  2005-11-23       Impact factor: 6.968

2.  Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue.

Authors:  H J Nielsen; U Hansen; I J Christensen; C M Reimert; N Brünner; F Moesgaard
Journal:  J Pathol       Date:  1999-12       Impact factor: 7.996

3.  The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus.

Authors:  G O Elpek; T Gelen; N H Aksoy; A Erdoğan; L Dertsiz; A Demircan; N Keleş
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

4.  Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.

Authors:  Hiromichi Kawaida; Koji Kono; Akihiro Takahashi; Hidemitsu Sugai; Kosaku Mimura; Naoto Miyagawa; Hideo Omata; Akishi Ooi; Hideki Fujii
Journal:  J Surg Res       Date:  2005-03       Impact factor: 2.192

5.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

Review 6.  Regulatory T cells in cancer.

Authors:  Marc Beyer; Joachim L Schultze
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  Mast cells and angiogenesis in gastric carcinoma.

Authors:  Domenico Ribatti; Diego Guidolin; Andrea Marzullo; Beatrice Nico; Tiziana Annese; Vincenzo Benagiano; Enrico Crivellato
Journal:  Int J Exp Pathol       Date:  2010-04-20       Impact factor: 1.925

Review 9.  The controversial role of mast cells in tumor growth.

Authors:  Domenico Ribatti; Enrico Crivellato
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

10.  Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.

Authors:  Shuji Ogino; Kaori Shima; Yoshifumi Baba; Katsuhiko Nosho; Natsumi Irahara; Shoko Kure; Li Chen; Saori Toyoda; Gregory J Kirkner; Y Lynn Wang; Edward L Giovannucci; Charles S Fuchs
Journal:  Gastroenterology       Date:  2008-12-24       Impact factor: 33.883

View more
  9 in total

1.  Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Authors:  A Jafarzadeh; H Fooladseresht; K Minaee; M R Bazrafshani; A Khosravimashizi; M Nemati; M Mohammadizadeh; M M Mohammadi; A Ghaderi
Journal:  Tumour Biol       Date:  2014-10-22

Review 2.  Targeting mast cells in gastric cancer with special reference to bone metastases.

Authors:  Christian Leporini; Michele Ammendola; Ilaria Marech; Giuseppe Sammarco; Rosario Sacco; Cosmo Damiano Gadaleta; Caroline Oakley; Emilio Russo; Giovambattista De Sarro; Girolamo Ranieri
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

3.  Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery.

Authors:  Michele Ammendola; Rosario Sacco; Valeria Zuccalà; Maria Luposella; Rosa Patruno; Pietro Gadaleta; Nicola Zizzo; Cosmo Damiano Gadaleta; Giovambattista De Sarro; Giuseppe Sammarco; Mihai Oltean; Girolamo Ranieri
Journal:  Int J Mol Sci       Date:  2016-11-15       Impact factor: 5.923

4.  Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance.

Authors:  Michele Ammendola; Rosario Sacco; Giuseppina Vescio; Valeria Zuccalà; Maria Luposella; Rosa Patruno; Nicola Zizzo; Claudia Gadaleta; Ilaria Marech; Roberta Ruggieri; Ibrahim Furkan Kocak; Taner Ozgurtas; Cosmo Damiano Gadaleta; Giuseppe Sammarco; Girolamo Ranieri
Journal:  Therap Adv Gastroenterol       Date:  2017-02-01       Impact factor: 4.409

5.  IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.

Authors:  Moritz F Eissmann; Christine Dijkstra; Andrew Jarnicki; Toby Phesse; Jamina Brunnberg; Ashleigh R Poh; Nima Etemadi; Evelyn Tsantikos; Stefan Thiem; Nicholas D Huntington; Margaret L Hibbs; Alex Boussioutas; Michele A Grimbaldeston; Michael Buchert; Robert J J O'Donoghue; Frederick Masson; Matthias Ernst
Journal:  Nat Commun       Date:  2019-06-21       Impact factor: 14.919

6.  IL‑33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway.

Authors:  Ning Huang; Xing Cui; Wen Li; Chunlai Zhang; Liqing Liu; Jinxing Li
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

7.  Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically Treated.

Authors:  Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Giuseppe Donato; Valeria Zuccalà; Roberto Romano; Maria Luposella; Rosa Patruno; Carlo Vallicelli; Giorgio Maria Verdecchia; Davide Cavaliere; Severino Montemurro; Girolamo Ranieri
Journal:  Gastroenterol Res Pract       Date:  2013-11-20       Impact factor: 2.260

8.  Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery.

Authors:  Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Giuseppe Donato; Valeria Zuccalà; Maria Luposella; Rosa Patruno; Ilaria Marech; Severino Montemurro; Nicola Zizzo; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Gastroenterol Res Pract       Date:  2014-06-04       Impact factor: 2.260

9.  Tumor-Associated Macrophages and Mast Cells Positive to Tryptase Are Correlated with Angiogenesis in Surgically-Treated Gastric Cancer Patients.

Authors:  Giuseppe Sammarco; Cosmo Damiano Gadaleta; Valeria Zuccalà; Emre Albayrak; Rosa Patruno; Pietro Milella; Rosario Sacco; Michele Ammendola; Girolamo Ranieri
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.